Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Huaxing Pharmaceutical Technology is a specialized chemical and pharmaceutical company based in Nanjing, China, focused on the research, development, and production of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Established in 2001, the company operates as a contract research organization (CRO) and contract development and manufacturing organization (CDMO) serving the global life sciences industry. Its core expertise lies in custom synthesis and the process optimization of complex organic molecules, particularly pyridine and pyrimidine derivatives. The company provides essential building blocks for therapeutic areas such as oncology, cardiovascular health, and anti-viral treatments. Nanjing Huaxing maintains modern R&D laboratories and manufacturing facilities that adhere to international quality standards to support global drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Huaxing Pharmaceutical Technology.